Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

Human platelet antigen-3 polymorphism as a risk factor for rheumatological manifestations in hepatitis C.

Medolago NB, Ferrasi AC, Rocha OMD, Pardini MIMC, Grotto RMT, Galvani AF, Silva GF.

Rev Soc Bras Med Trop. 2020 Jan 27;53:e20190210. doi: 10.1590/0037-8682-0210-2019. eCollection 2020.

2.

A kinetics-based approach to amyloid PET semi-quantification.

Chincarini A, Peira E, Corosu M, Morbelli S, Bauckneht M, Capitanio S, Pardini M, Arnaldi D, Vellani C, D'Ambrosio D, Garibotto V, Assal F, Paghera B, Savelli G, Stefanelli A, Guerra UP, Nobili F.

Eur J Nucl Med Mol Imaging. 2020 Jan 25. doi: 10.1007/s00259-020-04689-y. [Epub ahead of print]

PMID:
31982991
3.

Clinical and MRI Predictors of Conversion From Mild Behavioural Impairment to Dementia.

Orso B, Mattei C, Arnaldi D, Massa F, Serafini G, Plantone D, Doglione E, Grafman J, Nobili F, Pardini M.

Am J Geriatr Psychiatry. 2019 Dec 17. pii: S1064-7481(19)30586-X. doi: 10.1016/j.jagp.2019.12.007. [Epub ahead of print]

PMID:
31928846
4.

Metabolic network abnormalities in drug-naïve Parkinson's Disease.

Schindlbeck KA, Lucas-Jiménez O, Tang CC, Morbelli S, Arnaldi D, Pardini M, Pagani M, Ibarretxe-Bilbao N, Ojeda N, Nobili F, Eidelberg D.

Mov Disord. 2019 Dec 24. doi: 10.1002/mds.27960. [Epub ahead of print]

PMID:
31872507
5.

Metabolic correlates of dopaminergic loss in dementia with lewy bodies.

Huber M, Beyer L, Prix C, Schönecker S, Palleis C, Rauchmann BS, Morbelli S, Chincarini A, Bruffaerts R, Vandenberghe R, Van Laere K, Kramberger MG, Trost M, Grmek M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Vöglein J, Schnabel J, Unterrainer M, Perneczky R, Pogarell O, Buerger K, Catak C, Bartenstein P, Cumming P, Ewers M, Danek A, Levin J, Aarsland D, Nobili F, Rominger A, Brendel M.

Mov Disord. 2019 Dec 16. doi: 10.1002/mds.27945. [Epub ahead of print]

6.

Molecular imaging of multiple sclerosis: from the clinical demand to novel radiotracers.

Bauckneht M, Capitanio S, Raffa S, Roccatagliata L, Pardini M, Lapucci C, Marini C, Sambuceti G, Inglese M, Gallo P, Cecchin D, Nobili F, Morbelli S.

EJNMMI Radiopharm Chem. 2019 Apr 8;4(1):6. doi: 10.1186/s41181-019-0058-3. Review.

7.

Serum neurofilament light chain rate of change in Alzheimer's disease: potentials applications and notes of caution.

Massa F, Meli R, Morbelli S, Nobili F, Pardini M.

Ann Transl Med. 2019 Jul;7(Suppl 3):S133. doi: 10.21037/atm.2019.05.81. No abstract available.

8.

HPA-1a/1b could be considered a molecular predictor of poor prognosis in chronic hepatitis C.

Grotto RMT, Santos FM, Picelli N, Silva GF, Ferrasi AC, Sarnighausen VCR, Pardini MIMC.

Rev Soc Bras Med Trop. 2019 Jun 27;52:e20170427. doi: 10.1590/0037-8682-0427-2017.

9.

Defining responders to therapies by a statistical modeling approach applied to randomized clinical trial data.

Bovis F, Carmisciano L, Signori A, Pardini M, Steinerman JR, Li T, Tansy AP, Sormani MP.

BMC Med. 2019 Jun 18;17(1):113. doi: 10.1186/s12916-019-1345-2.

10.

Periventricular magnetisation transfer ratio abnormalities in multiple sclerosis improve after alemtuzumab.

Brown JWL, Prados Carrasco F, Eshaghi A, Sudre CH, Button T, Pardini M, Samson RS, Ourselin S, Wheeler-Kingshott CAG, Jones JL, Coles AJ, Chard DT.

Mult Scler. 2019 Jun 6:1352458519852093. doi: 10.1177/1352458519852093. [Epub ahead of print]

PMID:
31169059
11.

Explanation for the signs and symptoms of tooth eruption: mast cells.

Franzolin SOB, Pardini MIMC, Francischone LA, Deffune E, Consolaro A.

Dental Press J Orthod. 2019 May 20;24(2):20-31. doi: 10.1590/2177-6709.24.2.020-031.oin.

12.

Different MRI patterns in MS worsening after stopping fingolimod.

Lapucci C, Baroncini D, Cellerino M, Boffa G, Callegari I, Pardini M, Novi G, Sormani MP, Mancardi GL, Ghezzi A, Zaffaroni M, Uccelli A, Inglese M, Roccatagliata L.

Neurol Neuroimmunol Neuroinflamm. 2019 Apr 16;6(4):e566. doi: 10.1212/NXI.0000000000000566. eCollection 2019 Jul.

13.

Semi-quantification and grading of amyloid PET: A project of the European Alzheimer's Disease Consortium (EADC).

Chincarini A, Peira E, Morbelli S, Pardini M, Bauckneht M, Arbizu J, Castelo-Branco M, Büsing KA, de Mendonça A, Didic M, Dottorini M, Engelborghs S, Ferrarese C, Frisoni GB, Garibotto V, Guedj E, Hausner L, Hugon J, Verhaeghe J, Mecocci P, Musarra M, Queneau M, Riverol M, Santana I, Guerra UP, Nobili F.

Neuroimage Clin. 2019;23:101846. doi: 10.1016/j.nicl.2019.101846. Epub 2019 May 4.

14.

The Combination Rifampin-Nitazoxanide, but Not Rifampin-Isoniazid-Pyrazinamide-Ethambutol, Kills Dormant Mycobacterium tuberculosis in Hypoxia at Neutral pH.

Iacobino A, Giannoni F, Pardini M, Piccaro G, Fattorini L.

Antimicrob Agents Chemother. 2019 Jun 24;63(7). pii: e00273-19. doi: 10.1128/AAC.00273-19. Print 2019 Jul.

15.

Left rostrolateral prefrontal cortex lesions reduce suicidal ideation in penetrating traumatic brain injury.

Pardini M, Grafman J, Raymont V, Amore M, Serafini G, Koenigs M, Krueger F.

CNS Spectr. 2020 Feb;25(1):24-31. doi: 10.1017/S1092852918001694.

PMID:
30968811
16.

Magnetisation transfer ratio abnormalities in primary and secondary progressive multiple sclerosis.

Brown JWL, Chowdhury A, Kanber B, Prados Carrasco F, Eshaghi A, Sudre CH, Pardini M, Samson RS, van de Pavert SH, Wheeler-Kingshott CG, Chard DT.

Mult Scler. 2019 Apr 8:1352458519841810. doi: 10.1177/1352458519841810. [Epub ahead of print]

PMID:
30957691
17.

CSF oligoclonal bands and normal appearing white matter periventricular damage in patients with clinically isolated syndrome suggestive of MS.

Pardini M, Gualco L, Bommarito G, Roccatagliata L, Schiavi S, Solaro C, Mancardi G, Uccelli A, Capello E, Inglese M.

Mult Scler Relat Disord. 2019 Jun;31:93-96. doi: 10.1016/j.msard.2019.03.027. Epub 2019 Apr 2.

PMID:
30953954
18.

Multiple sclerosis: clinical trial design 2019.

Pardini M, Cutter G, Sormani MP.

Curr Opin Neurol. 2019 Jun;32(3):358-364. doi: 10.1097/WCO.0000000000000697. Review.

PMID:
30950845
19.

Default Mode Network Structural Integrity and Cerebellar Connectivity Predict Information Processing Speed Deficit in Multiple Sclerosis.

Savini G, Pardini M, Castellazzi G, Lascialfari A, Chard D, D'Angelo E, Gandini Wheeler-Kingshott CAM.

Front Cell Neurosci. 2019 Feb 11;13:21. doi: 10.3389/fncel.2019.00021. eCollection 2019.

20.

How much do periventricular lesions assist in distinguishing migraine with aura from CIS?

Lapucci C, Saitta L, Bommarito G, Sormani MP, Pardini M, Bonzano L, Mancardi GL, Gasperini C, Giorgio A, Inglese M, De Stefano N, Roccatagliata L.

Neurology. 2019 Apr 9;92(15):e1739-e1744. doi: 10.1212/WNL.0000000000007266. Epub 2019 Mar 8.

PMID:
30850445
21.

Metabolic patterns across core features in dementia with lewy bodies.

Morbelli S, Chincarini A, Brendel M, Rominger A, Bruffaerts R, Vandenberghe R, Kramberger MG, Trost M, Garibotto V, Nicastro N, Frisoni GB, Lemstra AW, van der Zande J, Pilotto A, Padovani A, Garcia-Ptacek S, Savitcheva I, Ochoa-Figueroa MA, Davidsson A, Camacho V, Peira E, Arnaldi D, Bauckneht M, Pardini M, Sambuceti G, Aarsland D, Nobili F.

Ann Neurol. 2019 May;85(5):715-725. doi: 10.1002/ana.25453. Epub 2019 Mar 22.

PMID:
30805951
22.

Head-to-Head Comparison among Semi-Quantification Tools of Brain FDG-PET to Aid the Diagnosis of Prodromal Alzheimer's Disease.

Brugnolo A, De Carli F, Pagani M, Morbelli S, Jonsson C, Chincarini A, Frisoni GB, Galluzzi S, Perneczky R, Drzezga A, van Berckel BNM, Ossenkoppele R, Didic M, Guedj E, Arnaldi D, Massa F, Grazzini M, Pardini M, Mecocci P, Dottorini ME, Bauckneht M, Sambuceti G, Nobili F.

J Alzheimers Dis. 2019;68(1):383-394. doi: 10.3233/JAD-181022.

PMID:
30776000
23.

FDG-PET patterns associated with underlying pathology in corticobasal syndrome.

Pardini M, Huey ED, Spina S, Kreisl WC, Morbelli S, Wassermann EM, Nobili F, Ghetti B, Grafman J.

Neurology. 2019 Mar 5;92(10):e1121-e1135. doi: 10.1212/WNL.0000000000007038. Epub 2019 Jan 30.

PMID:
30700592
24.

Cytokine Modulation in Breast Cancer Patients Undergoing Radiotherapy: A Revision of the Most Recent Studies.

Marconi R, Serafini A, Giovanetti A, Bartoleschi C, Pardini MC, Bossi G, Strigari L.

Int J Mol Sci. 2019 Jan 17;20(2). pii: E382. doi: 10.3390/ijms20020382. Review.

25.

Neuroimaging findings and clinical trajectories of Lewy body disease in patients with MCI.

Massa F, Arnaldi D, De Cesari F, Girtler N, Brugnolo A, Grazzini M, Bauckneht M, Meli R, Morbelli S, Pardini M, Sambuceti G, De Carli F, Tiraboschi P, Nobili F.

Neurobiol Aging. 2019 Apr;76:9-17. doi: 10.1016/j.neurobiolaging.2018.12.001. Epub 2018 Dec 13.

PMID:
30611093
26.

Explicit and implicit experience of own's body in painful musculoskeletal disorders and rheumatic diseases: A scoping review protocol of available quantitative and qualitative evidence.

Viceconti A, Camerone EM, Luzzi D, Pardini M, Ristori D, Gallace A, Testa M.

SAGE Open Med. 2018 Dec 18;6:2050312118820026. doi: 10.1177/2050312118820026. eCollection 2018.

27.

A new frontier for amyloid PET imaging: multiple sclerosis.

Morbelli S, Bauckneht M, Capitanio S, Pardini M, Roccatagliata L, Nobili F.

Eur J Nucl Med Mol Imaging. 2019 Feb;46(2):276-279. doi: 10.1007/s00259-018-4232-8. Epub 2018 Dec 15. No abstract available.

PMID:
30554257
28.

Ecological impact of isolated cognitive relapses in MS.

Meli R, Roccatagliata L, Capello E, Bruschi N, Uccelli A, Mancardi G, Inglese M, Pardini M.

Mult Scler. 2020 Jan;26(1):114-117. doi: 10.1177/1352458518813722. Epub 2018 Nov 15.

PMID:
30430928
29.

Brain activity pattern changes after adaptive working memory training in multiple sclerosis.

Bonzano L, Pedullà L, Pardini M, Tacchino A, Zaratin P, Battaglia MA, Brichetto G, Bove M.

Brain Imaging Behav. 2020 Feb;14(1):142-154. doi: 10.1007/s11682-018-9984-z.

30.

Differential clinical characteristics and possible predictors of bipolarity in a sample of unipolar and bipolar inpatients.

Serafini G, Lamis D, Canepa G, Aguglia A, Monacelli F, Pardini M, Pompili M, Amore M.

Psychiatry Res. 2018 Dec;270:1099-1104. doi: 10.1016/j.psychres.2018.06.041. Epub 2018 Jun 20.

PMID:
30342796
31.

Caregiving preferences and advance care planning among older adults living with HIV.

Nguyen AL, Seal D, Bruce O, Dalton M, Palmer A, Pardini M, Quiroga B, Ryu J, Soliman S, Welty JC, Younus I.

AIDS Care. 2019 Feb;31(2):243-249. doi: 10.1080/09540121.2018.1515472. Epub 2018 Aug 25.

PMID:
30146895
32.

Osteopathic Manipulative Therapy and Multiple Sclerosis: A Proof-of-Concept Study.

Cordano C, Armezzani A, Veroni J, Pardini M, Sassos D, Infante MT, Tacchino A, Lapucci C, Cellerino M, Calabrò V, Ciullo L, Nourbakhsh B.

J Am Osteopath Assoc. 2018 Aug 1;118(8):531-536. doi: 10.7556/jaoa.2018.121.

PMID:
30073336
33.

Cord cross-sectional area at foramen magnum as a correlate of disability in amyotrophic lateral sclerosis.

Piaggio N, Pardini M, Roccatagliata L, Scialò C, Cabona C, Bonzano L, Inglese M, Mancardi GL, Caponnetto C.

Eur Radiol Exp. 2018 Jun 22;2:13. doi: 10.1186/s41747-018-0045-6. eCollection 2018 Dec.

34.

Hepatitis D infection in Brazil: Prevalence and geographical distribution of anti-Delta antibody.

Lago BV, Mello FCA, Barros TM, Mello VM, Villar LM, Lewis-Ximenez LL, Pardini MIMC, Lampe E; Brazilian Hepatitis B Research Group.

J Med Virol. 2018 Aug;90(8):1358-1363. doi: 10.1002/jmv.25196. Epub 2018 May 1.

PMID:
29663457
35.

Metabolic correlates of reserve and resilience in MCI due to Alzheimer's Disease (AD).

Bauckneht M, Chincarini A, Piva R, Arnaldi D, Girtler N, Massa F, Pardini M, Grazzini M, Efeturk H, Pagani M, Sambuceti G, Nobili F, Morbelli S.

Alzheimers Res Ther. 2018 Apr 3;10(1):35. doi: 10.1186/s13195-018-0366-y.

36.

Response to the commentary of Yates RL and DeLuca GC on the study: HLA-DRB1*1501 associations with magnetic resonance imaging measures of grey matter pathology in multiple sclerosis.

Yaldizli Ö, Sethi V, Pardini M, Tur C, Mok KY, Muhlert N, Liu Z, Samson RS, Wheeler-Kingshott CAM, Yousry TA, Houlden H, Hardy J, Miller DH, Chard DT.

Mult Scler Relat Disord. 2018 Jan;19:168-170. doi: 10.1016/j.msard.2016.08.006. Epub 2016 Aug 12. No abstract available.

PMID:
29409599
37.

Mycobacterium tuberculosis-induced miR-155 subverts autophagy by targeting ATG3 in human dendritic cells.

Etna MP, Sinigaglia A, Grassi A, Giacomini E, Romagnoli A, Pardini M, Severa M, Cruciani M, Rizzo F, Anastasiadou E, Di Camillo B, Barzon L, Fimia GM, Manganelli R, Coccia EM.

PLoS Pathog. 2018 Jan 4;14(1):e1006790. doi: 10.1371/journal.ppat.1006790. eCollection 2018 Jan.

38.

Systematic assessment and characterization of chronic pain in multiple sclerosis patients.

Ferraro D, Plantone D, Morselli F, Dallari G, Simone AM, Vitetta F, Sola P, Primiano G, Nociti V, Pardini M, Mirabella M, Vollono C.

Neurol Sci. 2018 Mar;39(3):445-453. doi: 10.1007/s10072-017-3217-x. Epub 2017 Dec 9.

PMID:
29224058
39.

Prediction of cognitive worsening in de novo Parkinson's disease: Clinical use of biomarkers.

Arnaldi D, De Carli F, Famà F, Brugnolo A, Girtler N, Picco A, Pardini M, Accardo J, Proietti L, Massa F, Bauckneht M, Morbelli S, Sambuceti G, Nobili F.

Mov Disord. 2017 Dec;32(12):1738-1747. doi: 10.1002/mds.27190. Epub 2017 Nov 9.

PMID:
29119593
40.

A method permissive to fixation and permeabilization for the multiparametric analysis of apoptotic and necrotic cell phenotype by flow cytometry.

Mariotti S, Pardini M, Teloni R, Gagliardi MC, Fraziano M, Nisini R.

Cytometry A. 2017 Nov;91(11):1115-1124. doi: 10.1002/cyto.a.23268. Epub 2017 Oct 26.

41.

Clinical trial design for progressive MS trials.

Pardini M, Cutter G, Sormani MP.

Mult Scler. 2017 Oct;23(12):1642-1648. doi: 10.1177/1352458517729461. Review.

PMID:
29041873
42.

The intricate interplay between MSI and polymorphisms of DNA repair enzymes in gastric cancer H.pylori associated.

Silva-Fernandes IJL, Oliveira ES, Santos JC, Ribeiro ML, Ferrasi AC, Pardini MIMC, Burbano RMR, Rabenhorst SHB.

Mutagenesis. 2017 Jul 1;32(4):471-478. doi: 10.1093/mutage/gex013.

PMID:
28927196
43.

Possible predictors of age at illness onset and illness duration in a cohort study comparing younger adults and older major affective patients.

Serafini G, Gonda X, Monacelli F, Pardini M, Pompili M, Rihmer Z, Amore M.

J Affect Disord. 2018 Jan 1;225:691-701. doi: 10.1016/j.jad.2017.08.077. Epub 2017 Aug 31.

PMID:
28917196
44.

The relationship between cortical lesions and periventricular NAWM abnormalities suggests a shared mechanism of injury in primary-progressive MS.

Pardini M, Petracca M, Harel A, Fleysher L, Oesingmann N, Bommarito G, Fabian M, Chard D, Lublin F, Inglese M.

Neuroimage Clin. 2017 Jul 4;16:111-115. doi: 10.1016/j.nicl.2017.07.001. eCollection 2017.

45.

18F-FDG PET diagnostic and prognostic patterns do not overlap in Alzheimer's disease (AD) patients at the mild cognitive impairment (MCI) stage.

Morbelli S, Bauckneht M, Arnaldi D, Picco A, Pardini M, Brugnolo A, Buschiazzo A, Pagani M, Girtler N, Nieri A, Chincarini A, De Carli F, Sambuceti G, Nobili F.

Eur J Nucl Med Mol Imaging. 2017 Nov;44(12):2073-2083. doi: 10.1007/s00259-017-3790-5. Epub 2017 Aug 7.

PMID:
28785843
46.

Assessing Repair in Multiple Sclerosis: Outcomes for Phase II Clinical Trials.

Sormani MP, Pardini M.

Neurotherapeutics. 2017 Oct;14(4):924-933. doi: 10.1007/s13311-017-0558-3. Review.

47.

Nationwide overview of the distribution of hepatitis B virus genotypes in Brazil: a 1000-sample multicentre study.

Lampe E, Mello FCA, do Espírito-Santo MP, Oliveira CMC, Bertolini DA, Gonçales NSL, Moreira RC, Fernandes CAS, Nascimento HCL, Grotto RMT, Pardini MIMC, On Behalf Of The Brazilian Hepatitis B Research Group.

J Gen Virol. 2017 Jun;98(6):1389-1398. doi: 10.1099/jgv.0.000789. Epub 2017 Jun 20.

48.

ARIANNA: A research environment for neuroimaging studies in autism spectrum disorders.

Retico A, Arezzini S, Bosco P, Calderoni S, Ciampa A, Coscetti S, Cuomo S, De Santis L, Fabiani D, Fantacci ME, Giuliano A, Mazzoni E, Mercatali P, Miscali G, Pardini M, Prosperi M, Romano F, Tamburini E, Tosetti M, Muratori F.

Comput Biol Med. 2017 Aug 1;87:1-7. doi: 10.1016/j.compbiomed.2017.05.017. Epub 2017 May 17.

PMID:
28544911
49.

Composite MRI measures and short-term disability in patients with clinically isolated syndrome suggestive of MS.

Bommarito G, Bellini A, Pardini M, Solaro C, Roccatagliata L, Laroni A, Capello E, Mancardi GL, Uccelli A, Inglese M.

Mult Scler. 2018 Apr;24(5):623-631. doi: 10.1177/1352458517704077. Epub 2017 Apr 10.

PMID:
28394195
50.

Platelet-derived growth factor A mRNA in platelets is associated with the degree of hepatic fibrosis in chronic hepatitis C.

Tanikawa AA, Grotto RM, Silva GF, Ferrasi AC, Sarnighausen VC, Pardini MI.

Rev Soc Bras Med Trop. 2017 Jan-Feb;50(1):113-116. doi: 10.1590/0037-8682-0302-2016.

Supplemental Content

Loading ...
Support Center